• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes.

作者信息

Forsbeck K, Nilsson K, Kontoghiorghes G J

机构信息

Department of Pathology, Academic Hospital, Uppsala, Sweden.

出版信息

Eur J Haematol. 1987 Oct;39(4):318-25. doi: 10.1111/j.1600-0609.1987.tb00776.x.

DOI:10.1111/j.1600-0609.1987.tb00776.x
PMID:3691756
Abstract

Eight chelators - 8-hydroxyquinoline, 1-hydroxypyridine-2-thione (omadine), tropolone, pyridoxal isonicotinoyl hydrazone, 2-methyl-3-hydroxypyr-4-one (maltol), 1-methyl-3-hydroxypyrid-2-one, 1,2-dimethyl-3-hydroxypyrid-4-one and mimosine--and their iron complexes were tested on cells of the established human tumour cell lines K-562 (erythroleukaemic) and U-937 (monoblastoid) for their effects on a) cellular accumulation of iron provided by transferrin (Tf) via receptor-mediated endocytosis, b) specific cell surface binding of Tf, c) cell viability and, d) DNA synthesis. The lipophilic chelators suppressed the accumulation of Tf-supplied iron in the K-562 cells and less so in the U-937 cells, whereas the effects of the other chelators were closer to control range. The lipophilic chelators pyridoxal isonicotinoyl hydrazone, tropolone, 8-hydroxyquinoline and omadine were found to be cytotoxic in this order, with the U-937 being generally more sensitive than K-562. The presence of iron diminished the toxicity. The DNA synthesis was also affected, from a partial suppression in K-562 to a slight increase in U-937 in the presence of pyridoxal isonicotinoyl hydrazone and to strong suppression with 8-hydroxyquinoline and omadine. Addition of iron partially reversed the inhibition. The other chelators had low cytotoxic effects that disappeared upon iron saturation. Maltol, particularly in the absence of iron, 1,2-dimethyl-3-hydroxypyrid-4-one and 1-methyl-3-hydroxypyrid-2-one supported DNA synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Variation in iron accumulation, transferrin membrane binding and DNA synthesis in the K-562 and U-937 cell lines induced by chelators and their iron complexes.
Eur J Haematol. 1987 Oct;39(4):318-25. doi: 10.1111/j.1600-0609.1987.tb00776.x.
2
The iron metabolism of the human neuroblastoma cell: lack of relationship between the efficacy of iron chelation and the inhibition of DNA synthesis.人类神经母细胞瘤细胞的铁代谢:铁螯合功效与DNA合成抑制之间缺乏关联。
J Lab Clin Med. 1994 Nov;124(5):660-71.
3
Role of iron in the proliferation of the established human tumor cell lines U-937 and K-562: effects of suramin and a lipophilic iron chelator (PIH).铁在已建立的人肿瘤细胞系U - 937和K - 562增殖中的作用:苏拉明和亲脂性铁螯合剂(PIH)的影响
Scand J Haematol. 1986 Nov;37(5):429-37. doi: 10.1111/j.1600-0609.1986.tb02633.x.
4
Cytotoxic and DNA-inhibitory effects of iron chelators on human leukaemic cell lines.
Hematol Oncol. 1986 Jul-Sep;4(3):195-204. doi: 10.1002/hon.2900040303.
5
Characterization of iron uptake from transferrin by murine endothelial cells.小鼠内皮细胞对转铁蛋白中铁摄取的特征分析。
Endothelium. 2000;7(2):135-47. doi: 10.3109/10623320009072208.
6
Cytotoxic effects of the lipophilic iron chelator omadine.亲脂性铁螯合剂奥马汀的细胞毒性作用。
FEBS Lett. 1986 Aug 18;204(2):208-12. doi: 10.1016/0014-5793(86)80813-4.
7
Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes.吡哆醛异烟酰腙(PIH)类似物对细胞内铁的动员作用取决于铁螯合剂复合物的膜通透性。
Biochem Pharmacol. 2002 Dec 15;64(12):1689-701. doi: 10.1016/s0006-2952(02)01426-0.
8
Mobilization of iron from neoplastic cells by some iron chelators is an energy-dependent process.某些铁螯合剂从肿瘤细胞中动员铁是一个能量依赖过程。
Biochim Biophys Acta. 1997 May 16;1320(1):45-57. doi: 10.1016/s0005-2728(97)00008-x.
9
Free radical and cytotoxic effects of chelators and their iron complexes in the hepatocyte.螯合剂及其铁络合物在肝细胞中的自由基和细胞毒性作用。
Free Radic Res Commun. 1987;3(6):379-88. doi: 10.3109/10715768709088079.
10
Effect of novel 1-alkyl-3-hydroxy-2-methylpyrid-4-one chelators on uptake and release of iron from macrophages.新型1-烷基-3-羟基-2-甲基吡啶-4-酮螯合剂对巨噬细胞摄取和释放铁的影响。
Am J Hematol. 1990 May;34(1):21-5. doi: 10.1002/ajh.2830340106.

引用本文的文献

1
The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency.天然和合成螯合剂在医学中的重要性和必要性:有效治疗铁过载和缺铁症的前景增加。
Int J Mol Sci. 2024 Apr 25;25(9):4654. doi: 10.3390/ijms25094654.
2
Metal Complexes of Omadine (-Hydroxypyridine-2-thione): Differences of Antioxidant and Pro-Oxidant Behavior in Light and Dark Conditions with Possible Toxicity Implications.奥马汀(-羟基吡啶-2-硫酮)金属配合物:在光照和黑暗条件下抗氧化和促氧化行为的差异及其可能的毒性意义。
Molecules. 2023 May 20;28(10):4210. doi: 10.3390/molecules28104210.
3
New Iron Metabolic Pathways and Chelation Targeting Strategies Affecting the Treatment of All Types and Stages of Cancer.
新型铁代谢途径和螯合靶向策略影响各种类型和阶段癌症的治疗。
Int J Mol Sci. 2022 Nov 13;23(22):13990. doi: 10.3390/ijms232213990.
4
Questioning Established Theories and Treatment Methods Related to Iron and Other Metal Metabolic Changes, Affecting All Major Diseases and Billions of Patients.质疑与铁及其他金属代谢变化相关的既定理论和治疗方法,影响所有主要疾病和数十亿患者。
Int J Mol Sci. 2022 Jan 25;23(3):1364. doi: 10.3390/ijms23031364.
5
New Era in the Treatment of Iron Deficiency Anaemia Using Trimaltol Iron and Other Lipophilic Iron Chelator Complexes: Historical Perspectives of Discovery and Future Applications.使用三价麦芽酚铁和其他亲脂性铁螯合剂复合物治疗缺铁性贫血的新时代:发现的历史视角和未来应用。
Int J Mol Sci. 2021 May 24;22(11):5546. doi: 10.3390/ijms22115546.
6
Trying to Solve the Puzzle of the Interaction of Ascorbic Acid and Iron: Redox, Chelation and Therapeutic Implications.试图解开抗坏血酸与铁相互作用之谜:氧化还原、螯合作用及治疗意义
Medicines (Basel). 2020 Jul 30;7(8):45. doi: 10.3390/medicines7080045.
7
Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases.铁与螯合作用在生物化学和医学中的应用:控制铁代谢和治疗相关疾病的新方法。
Cells. 2020 Jun 12;9(6):1456. doi: 10.3390/cells9061456.
8
Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with non-transfusion-dependent thalassemia syndromes.去铁胺、去铁酮和地拉罗司铁螯合疗法治疗非输血依赖型地中海贫血综合征铁过载患者的疗效和安全性。
Drug Des Devel Ther. 2016 Jan 29;10:465-81. doi: 10.2147/DDDT.S79458. eCollection 2016.
9
Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology.用于铁过载、其他铁失衡疾病及自由基病理临床治疗的植物螯合剂
Molecules. 2015 Nov 23;20(11):20841-72. doi: 10.3390/molecules201119725.
10
Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.去铁酮治疗地中海贫血及其他病症铁过载的获益与风险:与去铁胺的流行病学及治疗学方面比较
Drug Saf. 2003;26(8):553-84. doi: 10.2165/00002018-200326080-00003.